July 7, 2022
The University of Cincinnati's Pooja Khatri commented on a new Danish study about how statins affect risk of stroke for Neurology Today.
August 1, 2022
Genetic Engineering & Biotechnology News featured the research of the University of Cincinnati's Agnes (Yu) Luo, PhD, who recently published a journal article showing a drug helped repair nervous system damage in animal models of stroke.
May 2, 2022
The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.
April 26, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was featured in a Spectrum News story about his research into biological factors that contribute to racial health disparities in patients with dementia.
May 5, 2022
The University of Cincinnati's LaTrice Montgomery was a guest on the Cannabis Man podcast to discuss the current state of cannabis research.
May 6, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, was featured in a VJOncology video discussing a recent Phase III glioma trial.
May 23, 2022
The University of Cincinnati's Caleb Adler discussed the recent death by suicide of singer Naomi Judd, risk factors for suicide and resources available for those struggling with mental health issues.
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
April 20, 2022
Consumer Affairs and Healthing Canada recently featured research from the University of Cincinnati showing patients seeking treatment for depression who have lower income and education and those who are members of minority populations tend to have worse treatment outcomes even when receiving equal access to treatment.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.